Fluoroquinolone Resistance in Neisseria gonorrhoeae: Fitness Cost or Benefit Full Text
The Journal of Infectious Diseases, 05/07/2012
Dillon JAR et al. – Fluoroquinolones were introduced for the treatment of gonorrhea infections in the late 1980s following the rise and worldwide dissemination of both plasmid–mediated and chromosomal resistance to penicillins and tetracyclines.



